If you deal with asthma, federal health officials recommend you stay away from a drug known as Serevent.
Researchers say the drug produces a significantly higher rate of complications. This compared to older treatments.
There’s a much more promising F-D-A report on the popular asthma drug Advair.
The drug does not appear to produce an increased risk of serious respiratory complications as seen with similar new medicines.